Results 241 to 250 of about 12,522 (293)

Beyond the 10%: Unraveling the genetic diversity in Turkish cystic fibrosis patients not eligible for CFTR modulators. [PDF]

Pediatr Pulmonol
Yıldız CA, Selçuk Balcı M, Karabulut Ş, Başer ZM, Yüksel Kalyoncu M, Metin Çakar N, Akkitap Yiğit MM, Baysal EE, Özdemircioğlu F, Uzunoğlu B, Taştan G, Ergenekon P, Gökdemir Y, Erdem Eralp E, Karakoç F, Ata P, Karadağ B.   +16 more
europepmc   +1 more source

Lentiviral vector gene therapy and CFTR modulators show comparable effectiveness in cystic fibrosis rat airway models. [PDF]

Gene Ther
McCarron A, Ling KM, Montgomery ST, Martinovich KM, Cmielewski P, Rout-Pitt N, Kicic A, Parsons D, Donnelley M.   +8 more
europepmc   +1 more source

Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators. [PDF]

Pulm Ther
Tomlinson OW, Mitchelmore P, Williams CA.   +2 more
europepmc   +1 more source

Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators. [PDF]

J Allergy Clin Immunol Glob
Mitropoulou G, Balmpouzis Z, Oberhansli-Wavre A, Morris M, Blanchon S, Sauty A, Koutsokera A.   +6 more
europepmc   +1 more source

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis. [PDF]

J Cyst Fibros
Jia S, Wang Y, Ross MH, Zuckerman JB, Murray S, Han MK, Cahalan SE, Lenhan BE, Best RN, Taylor-Cousar JL, Simon RH, Fitzgerald LJ, Troost JP, Sood SL, Gifford AH.   +14 more
europepmc   +1 more source

Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis Patients. [PDF]

J Clin Med
Pócsi M, Fila L, Péterfia C, Halász A, Szanto TG, Mészáros B, Major J, Laki I, Szabó H, Panyi G, Balogh I, Amaral MD, Macek M, Nagy B.   +13 more
europepmc   +1 more source

Organoid-guided synergistic treatment of minimal function CFTR mutations with CFTR modulators, roflumilast and simvastatin: a personalised approach. [PDF]

Eur Respir J
Spelier S, de Winter-de Groot K, Keijzer-Nieuwenhuijze N, Liem Y, van der Ent K, Beekman J, Kamphuis LS.   +6 more
europepmc   +1 more source

The Italian external quality assessment program for Cystic Fibrosis sweat chloride test: CFTR modulators and the impact of a new sweat test report form. [PDF]

Pract Lab Med
Cirilli N, Floridia G, Amato A, Padoan R, Censi F, Ferrari G, Raia V, Castaldo G, Capoluongo E, Taruscio D, Salvatore M.   +10 more
europepmc   +1 more source

Erratum: Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators. [PDF]

Am J Respir Crit Care Med
europepmc   +1 more source